Refined control of CRISPR-Cas9 gene editing in <i>Clostridium sporogenes</i>: the creation of recombinant strains for therapeutic applications.

Front Immunol · 2023 · PMC10585264 · PMID 37869009

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Values of P<0.05, P<0.01, P<0.001 were considered significant (∗), highly significant (∗∗), or extremely significant (∗∗∗) respectively.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.